Board Diversity

Capricor Therapeutics, Inc. News: Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

Learn More

2023

Board Diversity Matrix for Capricor Therapeutics, Inc.
As of January 1, 2024
Total Number of Directors - 9

Part I: Gender Identity
No Value	Female	Male	Non-Binary	Did Not Disclose Gender
Directors	2	7	0	0

Part II: Demographic Background
No value	Female	Male	Non-Binary	Did Not Disclose Gender
African American or Black	1	0	0	0
Alaskan Native or American Native	0	0	0	0
Asian	0	0	0	0
Hispanic or Latinx	0	0	0	0
Native Hawaiian or Pacific Islander	0	0	0	0
White	1	7	0	0
Two or More Races or Ethnicities	0	0	0	0
LGBTQ+	0
Did Not Disclose Demographic Background	0